NP / PA
Healthplus LLC
Healthplus LLC was paid $226K by Medicaid between Jun 2021 and Dec 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.
33Billing provider infoHEALTHPLUS LLC
MIDDLETON, MA 01949
MIDDLETON, MA 01949
33aNPI1821605502assigned 09/28/2020
33bProvider typePhysician Assistant
28Total paid$226K
24GClaims4,271
24DCodes billed7
24AFirst – last monthJun 2021 – Dec 2024
Compared with peers
Next to other Physician Assistant providers in Massachusetts
Rank by total paid#15 of 272
Median peer was paid$6K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 465 | $26K | |
| 2022 | 803 | $41K | |
| 2023 | 1,649 | $85K | |
| 2024incomplete | 1,354 | $73K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44% | 1,367 | 1,266 | $99K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 36% | 1,175 | 1,155 | $81K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 12% | 782 | 749 | $27K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.7% | 625 | 607 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.4% | 223 | 220 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 49 | 49 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 50 | 50 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAJEKODUNMI, AKINDELE (CEO/ MANAGING PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Pinnacle Medical Group, LLC | North Andover, MA | $489K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.